









Markets
/
Stocks
/
nasdaq-qtrx
/

Quanterix Corp

QTRX

3.425USD

-0.475-12.18%

Close 03/30, 16:00（ET）Quotes delayed by 15 min

69.34MMarket Cap

LossP/E TTM



Quanterix Corp

3.425

-0.475-12.18%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Quanterix Corp

Currency: USD Updated: 2026-03-27

Key Insights

Quanterix Corp's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 84 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 7.50.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Quanterix Corp's Score

Industry at a Glance

Industry Ranking

84 / 208

Overall Ranking

210 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Quanterix Corp Highlights

StrengthsRisks

Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 138.90M.

Overvalued

The company’s latest PE is -1.42, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 38.38M shares, decreasing 16.00% quarter-over-quarter.

Held by Invesco

Star Investor Invesco holds 101.04K shares of this stock.

Analyst Rating

Based on 4 analysts

Hold

Current Rating

7.500

Target Price

+92.31%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of Quanterix Corp is 6.87, ranking 105 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 43.85M, representing a year-over-year increase of 24.73%, while its net profit experienced a year-over-year increase of 98.80%.

Score

Industry at a Glance

Previous score

6.87

Change



Financials

6.68

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.19

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

5.26

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.96

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.23

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Quanterix Corp's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of Quanterix Corp is 8.67, ranking 14 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -1.42, which is 0.00% below the recent high of -1.42 and -2532.02% above the recent low of -37.50.

Score

Industry at a Glance

Previous score

8.67

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 84/208

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of Quanterix Corp is 6.00, ranking 175 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 6.50, with a high of 8.00 and a low of 5.00.

Score

Industry at a Glance

Previous score

6.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 4 analysts

Hold

Current Rating

7.500

Target Price

+109.50%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Quanterix Corp

QTRX

Boston Scientific Corp

BSX

Intuitive Surgical Inc

ISRG

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of Quanterix Corp is 5.88, ranking 171 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 5.55 and the support level at 2.57, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.02

Change

-0.14

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.160

Sell

RSI(14)

19.758

Oversold

STOCH(KDJ)(9,3,3)

8.340

Oversold

ATR(14)

0.300

High Vlolatility

CCI(14)

-137.734

Sell

Williams %R

96.089

Oversold

TRIX(12,20)

-1.686

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

3.738

Sell

MA10

4.056

Sell

MA20

4.599

Sell

MA50

5.642

Sell

MA100

6.131

Sell

MA200

5.829

Sell

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Quanterix Corp is 7.00, ranking 81 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 82.16%, representing a quarter-over-quarter increase of 11.92%. The largest institutional shareholder is The Vanguard, holding a total of 2.68M shares, representing 5.70% of shares outstanding, with 12.30% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Portolan Capital Management, L.L.C.

4.26M

+17.23%

Columbia Threadneedle Investments (UK)

3.14M

+0.28%

BlackRock Institutional Trust Company, N.A.

2.86M

+8.01%

The Vanguard Group, Inc.

Star Investors

2.65M

+4.69%

Telegraph Hill Partners

2.50M

Blue Water Life Science Advisors, LP.

957.75K

William Blair Investment Management, LLC

1.32M

+16.60%

Walt (David R)

1.86M

+0.14%

Columbia Threadneedle Investments (US)

1.11M

-0.19%

Invenomic Capital Management LP

1.39M

+21.67%

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Quanterix Corp is 4.92, ranking 93 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.27. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.